ALEMBIC Financials

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:3em;padding-top: 38px;;'>ALE</div>
Understanding current and past ALEMBIC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We suggest to use ALEMBIC LTD fundamental analysis to find out if markets are right now mispricing the company. Put another way you can use it to find out if ALEMBIC LTD is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-nine available fundamental indicators for ALEMBIC LTD, which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all ALEMBIC LTD financials, including its Gross Profit, Book Value Per Share and the relationship between Price to Book and Cash and Equivalents .

Search Fundamentals

With this module, you can analyze ALEMBIC financials for your investing period. You should be able to track the changes in ALEMBIC individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chance of Financial Distress

ALEMBIC LTD has    50 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of ods of distress for ALEMBIC stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

ALEMBIC Company Summary

Alembic Limited researches, develops, manufactures, and markets fermentation and chemistry based active pharmaceuticals ingredients . The company was founded in 1907 and is based in Vadodara, India. ALEMBIC LTD is traded on Bombay Stock Exchange in India.
InstrumentIndia Stock View All
ExchangeBombay Stock Exchange
Business AddressAlembic Road
IndustryDrug Manufacturers - Specialty & Generic
Phone91 26 5228 0550

ALEMBIC Key Financial Ratios

ALEMBIC Financial Ratios Relationships

ALEMBIC LTD is number one stock in price to sales category among related companies. It is number one stock in book value per share category among related companies creating about  5.53  of Book Value Per Share per Price to Sales.

ALEMBIC Market Fundamentals

 Change(%) 0.00 

About ALEMBIC Financials

What exactly are ALEMBIC Financials? Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include ALEMBIC income statement, its balance sheet, and the statement of cash flows. Potential ALEMBIC investors and stakeholders use the financial statements to determine how well the company is positioned to perform in the future. Although ALEMBIC investors may use each financial statement separately, they are all related. The changes in ALEMBIC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ALEMBIC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Alembic Limited researches, develops, manufactures, and markets fermentation and chemistry based active pharmaceuticals ingredients . The company was founded in 1907 and is based in Vadodara, India. ALEMBIC LTD is traded on Bombay Stock Exchange in India.
Please continue to Trending Equities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page